A myeloma prognosis is a quite rare form of cancer which affects the plasma cells found in the bone marrow. The bone marrow is the soft tissue found inside hollow bones.
In their normal function plasma cells produce antibodies or immunoglobulin as part of the immune system in the body. But when plasma cells grow cancerous they become out of control and can produce tumors which are known as plasmacytomas causing a myeloma prognosis
These cancer tumors often develop in a bone, but they can also develop in other body tissues. A solitary plasma cell tumor is called a plasmacytoma. Numerous tumors of the plasma cells result in a multiple myeloma prognosis.
Myeloma prognosis – Common symptoms
More bleeding and bruising: due to reduced levels of platelets in the blood
Fragile bones: due to the myeloma prognosis, cells send signals to dissolve bone but to grow bone
Physical Pain: Any bone can become infected, but painful back, hips and skull are most common.
Anemia: a reduction of red blood cells causes sufferers to become pale and weak
Nervous System Problems: due to total collapse of affected vertebrae. Also myeloma proteins may be toxic to nerve cells, producing weakness and a myeloma prognosis
High Blood Calcium. Related symptoms include dramatic thirst, excessive urination, constipation, dehydration,appetite loss, weakness, drowsiness and confusion. Extreme levels of calcium may cause a coma.
Kidney Problems: due to high quantities of myeloma protein affecting the kidneys.
Problems with fighting infections: due to a lack of normal white blood cells (leukopenia).
Myeloma Prognosis
Myeloma prognosis – Risk Factors
Age: Most myeloma prognosis sufferers are over 65. Less than 1% of cases involve people under 35.
Gender: Men have a greater chance of multiple myeloma prognosis as women.
Plasma Cell Diseases: Many people with Solitary Plasmacytoma can develop multiple myeloma prognosis.
Race: Myeloma is nearly twice as likely in black against white Americans.
Family History: A person with a parent or sibling with myeloma prognosis has a 4 times greater risk.
Obesity: Overweight people have a slightly greater risk.
Radiation Exposure
Myeloma prognosis – Detection
A Multiple Myeloma prognosis has little symptoms in the early stages and any occurring are often vague. Regular blood tests may have an abnormally high level of protein in the blood. If symptoms do point to Multiple Myeloma then often lab tests are required for blood and urine, bone x-rays. Bone marrow biopsies may be taken.
Quantitative Immunoglobulins: Frequently one type of immunoglobulin is high while others are much lower.
.Blood Counts: Low red cells and white cells levels
Beta-2 microglobulin: Not harmful, but high levels show that the disease is advanced and the myeloma prognosis worse.
Bone Marrow Biopsy: A tiny amount of liquid bone marrow is taken from the bone via a needle. The sample is looked at with a microscope for the presence of myeloma cells.
Electrophoresis: Peformed on urine and blood to calculate proportions of immunoglobulins
Imaging : CAT Scans,Bone X-rays, MRI’s andPET Scans can be performed to source and identify myeloma tumors in the body.
Myeloma prognosis – Conclusion
From a mixture of the patient’s symptoms, professional physical examination and the results from blood and urine tests and x-rays a doctor may prove a myeloma prognosis
Incoming search terms:
- fragile bones with myloma
- rare myeloma of bone marrow pronosis
